Global Pharmaceuticals & Biotech High Insider Buying

GSK

Market Cap: UK£76.4b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

CSL

Market Cap: AU$48.4b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Zoetis

Market Cap: US$33.6b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Waters

Market Cap: US$33.5b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Sino Biopharmaceutical

Market Cap: HK$93.1b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

CSPC Pharmaceutical Group

Market Cap: HK$87.9b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Elanco Animal Health

Market Cap: US$10.6b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Charles River Laboratories International

Market Cap: US$7.7b

Charles River Laboratories International, Inc.

Corcept Therapeutics

Market Cap: US$6.4b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Avantor

Market Cap: US$5.4b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Shanghai Junshi Biosciences

Market Cap: HK$38.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.

Indivior Pharmaceuticals

Market Cap: US$4.6b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Caris Life Sciences

Market Cap: US$4.5b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Hikma Pharmaceuticals

Market Cap: UK£3.1b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

Viking Therapeutics

Market Cap: US$3.6b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Telix Pharmaceuticals

Market Cap: AU$4.5b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Dyne Therapeutics

Market Cap: US$2.9b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

IDEAYA Biosciences

Market Cap: US$2.6b

A precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Grand Pharmaceutical Group

Market Cap: HK$19.2b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Bavarian Nordic

Market Cap: DKK 15.1b

Develops, manufactures, and supplies life-saving vaccines.

Kalbe Farma

Market Cap: Rp36.2t

Engages in the development, manufacture, and trading of pharmaceutical products in Indonesia.

AddLife

Market Cap: SEK 18.4b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

ADMA Biologics

Market Cap: US$2.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Mesoblast

Market Cap: AU$2.7b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Bonesupport Holding

Market Cap: SEK 16.9b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Generate Biomedicines

Market Cap: US$1.8b

Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States.

Oxford Nanopore Technologies

Market Cap: UK£1.3b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.

Palvella Therapeutics

Market Cap: US$1.7b

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.

AbCellera Biologics

Market Cap: US$1.6b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

MBX Biosciences

Market Cap: US$1.5b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Everest Medicines

Market Cap: HK$11.2b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

HBM Holdings

Market Cap: HK$10.2b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

Zenas BioPharma

Market Cap: US$1.3b

A clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies.

Neuren Pharmaceuticals

Market Cap: AU$1.7b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Harrow

Market Cap: US$1.2b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States.

EyePoint

Market Cap: US$1.1b

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.